ZA200206181B - Medicine containig anemonin as effective component for treating aseptic inflammation. - Google Patents
Medicine containig anemonin as effective component for treating aseptic inflammation. Download PDFInfo
- Publication number
- ZA200206181B ZA200206181B ZA200206181A ZA200206181A ZA200206181B ZA 200206181 B ZA200206181 B ZA 200206181B ZA 200206181 A ZA200206181 A ZA 200206181A ZA 200206181 A ZA200206181 A ZA 200206181A ZA 200206181 B ZA200206181 B ZA 200206181B
- Authority
- ZA
- South Africa
- Prior art keywords
- anemonin
- medicament
- clematis
- chinese herb
- extract
- Prior art date
Links
- JLUQTCXCAFSSLD-UHFFFAOYSA-N Anemonin Natural products C1=CC(=O)OC11C2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-UHFFFAOYSA-N 0.000 title claims description 120
- JLUQTCXCAFSSLD-NXEZZACHSA-N Anemonin Chemical compound C1=CC(=O)O[C@]11[C@@]2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-NXEZZACHSA-N 0.000 title claims description 118
- 239000003814 drug Substances 0.000 title claims description 65
- 206010061218 Inflammation Diseases 0.000 title claims description 52
- 230000004054 inflammatory process Effects 0.000 title claims description 51
- 229940079593 drug Drugs 0.000 title description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 69
- 239000000284 extract Substances 0.000 claims description 57
- 238000000034 method Methods 0.000 claims description 39
- 241000196324 Embryophyta Species 0.000 claims description 28
- 238000000605 extraction Methods 0.000 claims description 27
- 238000002360 preparation method Methods 0.000 claims description 25
- 241000823550 Ranunculus japonicus Species 0.000 claims description 24
- 208000002193 Pain Diseases 0.000 claims description 23
- 230000036407 pain Effects 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 230000000699 topical effect Effects 0.000 claims description 18
- 241001256368 Clematis chinensis Species 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 201000010099 disease Diseases 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000123887 Pulsatilla chinensis Species 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 12
- 241000218158 Clematis Species 0.000 claims description 11
- 210000003195 fascia Anatomy 0.000 claims description 11
- 241000415048 Anemone hupehensis Species 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- TYWXNGXVSZRXNA-NVZSGMJQSA-N Ranunculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1C=CC(=O)O1 TYWXNGXVSZRXNA-NVZSGMJQSA-N 0.000 claims description 9
- TYWXNGXVSZRXNA-UHFFFAOYSA-N Ranunculin Natural products OC1C(O)C(O)C(CO)OC1OCC1C=CC(=O)O1 TYWXNGXVSZRXNA-UHFFFAOYSA-N 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 8
- 206010034464 Periarthritis Diseases 0.000 claims description 7
- 208000008765 Sciatica Diseases 0.000 claims description 7
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 7
- 208000036319 cervical spondylosis Diseases 0.000 claims description 7
- 239000007924 injection Substances 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 7
- 239000000865 liniment Substances 0.000 claims description 7
- 229940040145 liniment Drugs 0.000 claims description 7
- 230000003387 muscular Effects 0.000 claims description 7
- 239000003973 paint Substances 0.000 claims description 7
- 201000003068 rheumatic fever Diseases 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 208000005801 spondylosis Diseases 0.000 claims description 7
- 208000011580 syndromic disease Diseases 0.000 claims description 7
- 201000008482 osteoarthritis Diseases 0.000 claims description 6
- 201000007094 prostatitis Diseases 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 206010000087 Abdominal pain upper Diseases 0.000 claims description 5
- 241000554905 Anemone raddeana Species 0.000 claims description 5
- 240000003285 Caltha palustris Species 0.000 claims description 5
- 235000008749 Caltha palustris Nutrition 0.000 claims description 5
- 241001598107 Imperata Species 0.000 claims description 5
- 206010050031 Muscle strain Diseases 0.000 claims description 5
- 206010029240 Neuritis Diseases 0.000 claims description 5
- 241000172739 Ranunculus chinensis Species 0.000 claims description 5
- 241001326116 Ranunculus sceleratus Species 0.000 claims description 5
- 208000002240 Tennis Elbow Diseases 0.000 claims description 5
- 208000004760 Tenosynovitis Diseases 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 239000010775 animal oil Substances 0.000 claims description 5
- 150000007522 mineralic acids Chemical class 0.000 claims description 5
- 239000004745 nonwoven fabric Substances 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 239000011505 plaster Substances 0.000 claims description 5
- 239000002243 precursor Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 239000000829 suppository Substances 0.000 claims description 5
- 235000021419 vinegar Nutrition 0.000 claims description 5
- 239000000052 vinegar Substances 0.000 claims description 5
- 241001586438 Aconitum scaposum Species 0.000 claims description 4
- 241001083548 Anemone Species 0.000 claims description 4
- 241000415078 Anemone hepatica Species 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 241000601157 Clematis angustifolia Species 0.000 claims description 4
- 241000601151 Clematis florida Species 0.000 claims description 4
- 241000915582 Clematis manshurica Species 0.000 claims description 4
- 241001255992 Clematis meyeniana Species 0.000 claims description 4
- 240000001285 Clematis paniculata Species 0.000 claims description 4
- 235000004801 Clematis paniculata Nutrition 0.000 claims description 4
- 241000601182 Clematis uncinata Species 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 241000206389 Helleborus Species 0.000 claims description 4
- 208000019695 Migraine disease Diseases 0.000 claims description 4
- 201000009053 Neurodermatitis Diseases 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 206010027599 migraine Diseases 0.000 claims description 4
- -1 anemonin compound Chemical class 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 230000002349 favourable effect Effects 0.000 claims 2
- 230000002045 lasting effect Effects 0.000 claims 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims 1
- RNYZJZKPGHQTJR-UHFFFAOYSA-N protoanemonin Chemical compound C=C1OC(=O)C=C1 RNYZJZKPGHQTJR-UHFFFAOYSA-N 0.000 description 58
- 235000008216 herbs Nutrition 0.000 description 25
- 239000002994 raw material Substances 0.000 description 20
- 238000012360 testing method Methods 0.000 description 15
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 244000025254 Cannabis sativa Species 0.000 description 10
- 210000000548 hind-foot Anatomy 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 210000002683 foot Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical group C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000002085 irritant Substances 0.000 description 6
- 231100000021 irritant Toxicity 0.000 description 6
- 230000002035 prolonged effect Effects 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 241000906633 Anemoneae Species 0.000 description 4
- 241000218206 Ranunculus Species 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 210000003405 ileum Anatomy 0.000 description 4
- 208000027866 inflammatory disease Diseases 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000000114 Pain Threshold Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000906635 Ranunculeae Species 0.000 description 3
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 230000037040 pain threshold Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 238000007803 cold maceration Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical group C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 2
- 238000007802 hot water maceration Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000035987 intoxication Effects 0.000 description 2
- 231100000566 intoxication Toxicity 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 210000001872 metatarsal bone Anatomy 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 206010049797 Calcification of muscle Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 244000297531 Lespedeza cuneata Species 0.000 description 1
- 241001007959 Mucuna birdwoodiana Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241001533116 Pittosporum glabratum Species 0.000 description 1
- 241000501113 Sargentodoxa cuneata Species 0.000 description 1
- 244000291333 Serissa japonica Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000727923 Tetrastigma obtectum Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002579 anti-swelling effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003789 metatarsus Anatomy 0.000 description 1
- 231100000324 minimal toxicity Toxicity 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00112680A CN1306818A (zh) | 2000-02-04 | 2000-02-04 | 一种用于治疗无菌性炎症的药物及提取方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200206181B true ZA200206181B (en) | 2003-08-04 |
Family
ID=4582521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200206181A ZA200206181B (en) | 2000-02-04 | 2002-08-02 | Medicine containig anemonin as effective component for treating aseptic inflammation. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20030064117A1 (fr) |
| EP (1) | EP1252893B1 (fr) |
| JP (1) | JP4198359B2 (fr) |
| KR (1) | KR100622614B1 (fr) |
| CN (2) | CN1306818A (fr) |
| AP (1) | AP1888A (fr) |
| AT (1) | ATE416779T1 (fr) |
| AU (1) | AU779940B2 (fr) |
| BR (1) | BR0108074A (fr) |
| CA (1) | CA2399123A1 (fr) |
| DE (1) | DE60136909D1 (fr) |
| EA (1) | EA006946B1 (fr) |
| ES (1) | ES2315271T3 (fr) |
| HK (1) | HK1049287B (fr) |
| MX (1) | MXPA02007358A (fr) |
| MY (1) | MY137752A (fr) |
| WO (1) | WO2001056583A1 (fr) |
| ZA (1) | ZA200206181B (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010100129A (ko) * | 2001-10-09 | 2001-11-14 | 황병조 | 할미꽃 및 무궁화 꽃으로부터 무좀약을 제조하는 방법제조방법 및 그에 의하여 제조되는 무좀약 |
| US6951833B2 (en) * | 2002-09-17 | 2005-10-04 | O'neil Deborah | Anti-microbial compositions |
| KR100515206B1 (ko) * | 2002-09-23 | 2005-09-16 | 김종석 | 백두옹 추출물을 주성분으로 함유하는 미백 화장용 조성물 |
| US20090068687A1 (en) * | 2004-01-14 | 2009-03-12 | The Hong Kong Polytechnic University | Screening platform for discovery of immunomodulatory activities in traditional medicine |
| CN100413501C (zh) * | 2006-03-06 | 2008-08-27 | 浙江大学 | 白头翁素透皮吸收贴片 |
| CN100370982C (zh) * | 2006-03-10 | 2008-02-27 | 浙江大学 | 白头翁素透皮凝胶剂 |
| US20090263456A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Methods and Compositions for Reducing Preventing and Treating Adhesives |
| JP5800454B2 (ja) * | 2008-05-23 | 2015-10-28 | 株式会社ノエビア | 皮膚外用剤、経口剤、抗酸化剤、抗老化剤、及び免疫賦活剤 |
| WO2010107150A1 (fr) * | 2009-03-20 | 2010-09-23 | (주)뉴메드 | Composition pharmaceutique pour la prévention et le traitement de maladies cérébrales ischémiques |
| CN101759706B (zh) * | 2009-10-20 | 2012-01-11 | 苏州派腾生物医药科技有限公司 | 一种白头翁素的制备方法 |
| KR101131719B1 (ko) * | 2011-04-11 | 2012-04-03 | 한국폴리텍바이오대학산학협력단 | 백두옹 추출물을 유효성분으로 포함하는 염증성 질환 치료 및 예방용 조성물 |
| CN102742920B (zh) * | 2012-07-17 | 2013-07-31 | 四川农业大学 | 从野棉花叶中提取酵母菌抑制剂的方法 |
| US8999403B2 (en) * | 2012-12-11 | 2015-04-07 | Avon Products, Inc. | Serissa japonica extracts and methods of use |
| CN103040965B (zh) * | 2012-12-13 | 2016-05-25 | 大兴安岭林格贝寒带生物科技股份有限公司 | 一种从野生石龙芮里提取总黄酮的生产工艺 |
| CN103599145B (zh) * | 2013-10-29 | 2016-04-06 | 贵阳中医学院 | 铁筷子提取物及其中有效成分的分离方法和所得化合物 |
| CN104337804A (zh) * | 2014-10-24 | 2015-02-11 | 中国人民解放军第三军医大学第三附属医院 | 白头翁素在制备治疗骨性关节炎的药物中的应用 |
| CN107029062A (zh) * | 2017-04-26 | 2017-08-11 | 宁波神能保健器材有限公司 | 治疗颈椎的中药及其制备方法 |
| KR102118068B1 (ko) * | 2018-07-09 | 2020-06-02 | 동의대학교 산학협력단 | 기능성 콘돔용 항균 코팅제 및 이를 포함하는 기능성 콘돔 |
| KR102091004B1 (ko) * | 2018-10-15 | 2020-03-19 | 국립낙동강생물자원관 | 젓가락나물 추출물을 이용한 피부 미백용 조성물 |
| KR102529752B1 (ko) | 2020-06-05 | 2023-05-11 | 김숭진 | 백두옹(Pulsatilla koreana)과 꿩의바람꽃(Anemone raddeana)의 가수분해추출물을 유효성분으로 포함하는 염증성질환 예방 또는 치료용 조성물 |
| CN114681474B (zh) * | 2022-05-10 | 2023-11-24 | 广西林洋药业有限公司 | 一种具有消肿止痒作用的组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3203863A (en) * | 1962-02-05 | 1965-08-31 | Lion Hamigaki Kk | Process for producing protoanemonin preparation |
| KR940000234B1 (ko) * | 1989-09-04 | 1994-01-12 | 김송배 | 신규 항암작용을 가지는 약학적 제제 및 제조방법 |
| CN2329301Y (zh) * | 1998-06-15 | 1999-07-21 | 孟继贤 | 消毒洁肤湿巾 |
-
2000
- 2000-02-04 CN CN00112680A patent/CN1306818A/zh active Pending
-
2001
- 2001-01-20 EA EA200200746A patent/EA006946B1/ru not_active IP Right Cessation
- 2001-01-20 EP EP01903570A patent/EP1252893B1/fr not_active Expired - Lifetime
- 2001-01-20 MX MXPA02007358A patent/MXPA02007358A/es active IP Right Grant
- 2001-01-20 ES ES01903570T patent/ES2315271T3/es not_active Expired - Lifetime
- 2001-01-20 DE DE60136909T patent/DE60136909D1/de not_active Expired - Lifetime
- 2001-01-20 AU AU31481/01A patent/AU779940B2/en not_active Ceased
- 2001-01-20 BR BR0108074-1A patent/BR0108074A/pt not_active IP Right Cessation
- 2001-01-20 KR KR1020027010053A patent/KR100622614B1/ko not_active IP Right Cessation
- 2001-01-20 JP JP2001556482A patent/JP4198359B2/ja not_active Expired - Fee Related
- 2001-01-20 AT AT01903570T patent/ATE416779T1/de not_active IP Right Cessation
- 2001-01-20 WO PCT/CN2001/000067 patent/WO2001056583A1/fr active IP Right Grant
- 2001-01-20 AP APAP/P/2002/002601A patent/AP1888A/en active
- 2001-01-20 CN CNB018027172A patent/CN1208056C/zh not_active Expired - Fee Related
- 2001-01-20 CA CA002399123A patent/CA2399123A1/fr not_active Abandoned
- 2001-08-07 MY MYPI20013717A patent/MY137752A/en unknown
-
2002
- 2002-05-29 US US10/156,407 patent/US20030064117A1/en not_active Abandoned
- 2002-08-02 ZA ZA200206181A patent/ZA200206181B/en unknown
-
2003
- 2003-03-03 HK HK03101550.7A patent/HK1049287B/zh not_active IP Right Cessation
-
2005
- 2005-11-14 US US11/272,092 patent/US7297353B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60136909D1 (de) | 2009-01-22 |
| EP1252893B1 (fr) | 2008-12-10 |
| HK1049287B (zh) | 2005-09-09 |
| US7297353B2 (en) | 2007-11-20 |
| AU3148101A (en) | 2001-08-14 |
| US20030064117A1 (en) | 2003-04-03 |
| JP4198359B2 (ja) | 2008-12-17 |
| CN1208056C (zh) | 2005-06-29 |
| AU779940B2 (en) | 2005-02-17 |
| MXPA02007358A (es) | 2002-12-09 |
| ATE416779T1 (de) | 2008-12-15 |
| KR100622614B1 (ko) | 2006-09-11 |
| EA006946B1 (ru) | 2006-06-30 |
| HK1049287A1 (en) | 2003-05-09 |
| ES2315271T3 (es) | 2009-04-01 |
| CA2399123A1 (fr) | 2001-08-09 |
| US20060062860A1 (en) | 2006-03-23 |
| AP2002002601A0 (en) | 2002-09-30 |
| JP2003521520A (ja) | 2003-07-15 |
| CN1388759A (zh) | 2003-01-01 |
| EP1252893A1 (fr) | 2002-10-30 |
| WO2001056583A1 (fr) | 2001-08-09 |
| AP1888A (en) | 2008-09-22 |
| EP1252893A4 (fr) | 2005-02-16 |
| EA200200746A1 (ru) | 2002-12-26 |
| KR20030016225A (ko) | 2003-02-26 |
| MY137752A (en) | 2009-03-31 |
| CN1306818A (zh) | 2001-08-08 |
| BR0108074A (pt) | 2003-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1252893B1 (fr) | Medicament contenant une anemonine efficace pour traiter les inflammations aseptiques | |
| US20080220084A1 (en) | Combination therapy for alleviating pain-related conditions | |
| US10076527B2 (en) | Standardized extract and its use in the manufacture of a medicament | |
| WO2010150245A1 (fr) | Compositions pharmaceutiques et cosmétiques contenant des extraits de graines et de fleurs de cannabis | |
| US4352796A (en) | Pharmaceutically active plant extract and composition thereof | |
| KR101192409B1 (ko) | 낙석등 건조 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 염증성 질환 예방 및 치료용 약제학적 조성물과 상기 분획물의 제조방법 | |
| CN108813465A (zh) | 一种无花果功能咀嚼片及其制备方法 | |
| KR20100092160A (ko) | 관절염 예방 또는 치료용 조성물 및 그 제조방법 | |
| KR100987211B1 (ko) | 항염증 및 항통증 작용을 갖는 관절염 예방 및 개선을 위한건강기능식품 | |
| KR20130094490A (ko) | 백합나무 수피 추출물을 유효 성분으로 함유하는 개선된 의약 제형 | |
| WO2018161890A1 (fr) | Application de berbérine dans la préparation d'un médicament pour le traitement d'une lésion aiguë de tissu mou | |
| RU2481111C1 (ru) | Способ профилактики язвообразования на слизистой оболочке желудка | |
| CN101693073A (zh) | 复方金凤喷雾剂及其制备方法 | |
| CN109350719A (zh) | 一种治疗神经性疾病的中药组合物及其制备方法 | |
| CN109908202A (zh) | 一种治疗高尿酸血症的药物组合物及其制备方法 | |
| CN109260217A (zh) | 3`-脱氧次黄嘌呤核苷在制备用于多种疾病药品、食品或保健品中的应用 | |
| US7288269B2 (en) | Asafetida extract as medicine for abstinence of drugs | |
| CN114470063A (zh) | 一种用于治疗软组织损伤的复方中药片 | |
| KR20110038386A (ko) | 할미꽃 추출물을 포함하는 통증 치료용 조성물 및 그 제조 방법 | |
| TWI277420B (en) | Medicine using anemonin as active pharmaceutical ingredient for treating aseptic inflammation | |
| CN1546143A (zh) | 一种补肾壮阳鹿阳强肾中药制剂及制备方法 | |
| CN106163535A (zh) | 包含胡桃萃取物的抗肥胖剂 | |
| KR20180132005A (ko) | 관절염 예방, 개선 또는 치료용 조성물 | |
| Tzoneva-Tyutyulkova | Rosa Damascena pharmacological effects and therapeutic use | |
| KR20170096737A (ko) | 관절염 예방, 개선 또는 치료용 조성물 |